In published research literature after 2010, AOD-9604 began to appear in combination protocols , as a secondary molecule added to GH combinations, GLP-1 agonists or regenerative peptides
The strongest published finding is from the foundational Biochemical Pharmacology study by Neelakantan et al.: in diet-induced obese mice, daily 5-Amino-1MQ administration produced reductions in body weight, white adipose tissue mass, and adipocyte size without any significant change in food intake
Current cardiology reviews , 9 (1), 3354
Long-term deficiency may lead to more serious health issues like anemia, nerve damage, and cognitive problems
Retrieved November 9, 2021 from Urbanski, G., Hamel, J.-F., Prouveur, B., Annweiler, C., Ghali, A., Cassereau, J., et al